Pharma Companies Turn to AI to Speed Up Drug Development, But Hit Hurdles
Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...
Biotech/pharma M&A to pick up in 2025 once regulatory uncertainty declines
With many biotechs and pharmas needing to fill impending revenue holes coming later in the decade, M&A is posed to pick up, but not until government and regulatory uncertainty settles down. Dealmaking ...
Hookipa Pharma stock hits 52-week low at $1.71 amid downturn
In a challenging year for biotech firms, Hookipa Pharma Inc (NASDAQ:HOOK). shares have tumbled to a 52-week low, touching down at $1.71. According to InvestingPro analysis, the company, known for its ...
Royalty Pharma targets $3B share buyback and projects 4-9% growth in 2025 portfolio receipts
Q4 2024 Management View CEO Pablo Legorreta highlighted strong 2024 performance, reporting $2.8 billion in portfolio receipts, at the high end of guidance and reflecting 13% growth in Royalty Receipts ...
Nuvectis pharma investor acquires $1.2 million in stock
LONDON—Marlio Charles Mosseri, a significant shareholder in Nuvectis Pharma , Inc. (NASDAQ:NVCT), has made a notable purchase of company stock. According to a recent filing, Mosseri acquired 240,000 ...
Hosted on MSN3d
Warren's Claim to Be Clean of Big Pharma Money Falls Apart as It's Revealed They Give Her Millions
After her fiery confrontation with Robert F. Kennedy Jr. during his confirmation hearing to lead the Department of Health and ...
Hosted on MSN20h
National Conference on 'Pharma Innovations' Organized by Sri Aurobindo Institute of Pharmacy
Sri Aurobindo Institute of Pharmacy (SAIP), Indore, successfully hosted a National Conference on "Pharma Innovations: ...